Supported by the National High Technology Research and Development Program of China (863 Program,2006AA02A308);the National Key Technologies Research and Development Program of China (2008ZX10002-016);the Beijing Municipal Key Project(H030230280410)
Objective To investigate the association between plasminogen activator inhibitor(PAI)-2 expression and invasive potential in hepatocellular carcinoma(HCC) cells.Methods The HCC cell lines with high,low,and non-metasta...
supported by the National Basic Research Program of China(Grant Nos.2011CB910601,2011CB910700,2010CB912700 and 2011CB505304);the National High Technology Research and Development Program of China (Grant No.2006AA02A308);National Natural Science Foundation of China(Grant Nos.30700356,30700988,30972909,81000192,81001470 and 81010064);Chinese State Key Project Specialized for Infectious Diseases (Grant Nos.2008ZX10002-016 and 2009ZX10004-103);the National Key Technologies R&D Program for New Drugs (Grant No.2009ZX09301-002);the International Scientific Collaboration Program (Grant Nos.2009DFB33070 and 2010DFA31260);State Key Laboratory of Proteomics(Grant Nos.SKLP-Y200901 and SKLP-O200901)
A non-invasive diagnostic approach is crucial for the evaluation of severity of liver disease,treatment decisions,and assessing drug efficacy.This study evaluated plasma proteomic profiling via an N-terminal isotope t...